Delivery Order SPE2DB22D3004-SPE2DB25FSD83
- Not listed
- The Defense Logistics Agency awarded a $1,239.90 delivery order to AmerisourceBergen Drug Corp for 30 units of Mesalamine 1,000 mg suppositories under a firm fixed-price contract. The delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement executed through the company's existing contract vehicle with DLA. The pharmaceutical product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $4,847.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mesalamine 1,000 mg suppositories (30-count supply) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside award represents a competitively procured transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Mesalamine 1,000 mg suppositories (30-count units) with a ceiling value of $6,756.20. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was awarded on a competitive basis without any set-aside designation. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.71 to AmerisourceBergen Drug Corp for Mesalamine 1,000 mg suppositories (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mesalamine 1,000 mg suppositories in a quantity of 30 units, with a ceiling value of $1,768.57. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.89, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price Delivery Order contract with a completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at twenty-five thousand six hundred eighty dollars to provide one thousand units of 1,000 mg mesalamine suppositories over a one day period from June 22 to June 23, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply needs....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.12, is a delivery order issued by the Defense Logistics Agency (DLA) for the procurement of 4,567,342,783 units of Mesalamine 1,000 mg suppositories. The contract has an ultimate completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,286.99 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine DR 1.2 GM on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSD83Delivery Order
The Defense Logistics Agency awarded a $2,378.71 delivery order to AmerisourceBergen Drug Corp for Mesalamine 1,000 mg suppositories (30-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive contracting process. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to deliver brand-name and generic pharmaceuticals, vaccines, and specialty medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/25/25 |